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Background: The rapid expansion of 16S rRNA gene sequencing in challenging clinical contexts has resulted in a
growing body of literature of variable quality. To a large extent, this is due to a failure to address spurious signal
that is characteristic of samples with low levels of bacteria and high levels of non-bacterial DNA. We have developed a
workflow based on the paired-end read Illumina MiSeq-based approach, which enables significant improvement in data
quality, post-sequencing. We demonstrate the efficacy of this methodology through its application to paediatric
upper-respiratory samples from several anatomical sites.
Results: A workflow for processing sequence data was developed based on commonly available tools. Data generated
from different sample types showed a marked variation in levels of non-bacterial signal and ‘contaminant’ bacterial
reads. Significant differences in the ability of reference databases to accurately assign identity to operational taxonomic
units (OTU) were observed. Three OTU-picking strategies were trialled as follows: de novo, open-reference and
closed-reference, with open-reference performing substantially better. Relative abundance of OTUs identified as
potential reagent contamination showed a strong inverse correlation with amplicon concentration allowing their
objective removal. The removal of the spurious signal showed the greatest improvement in sample types typically
containing low levels of bacteria and high levels of human DNA. A substantial impact of pre-filtering data and
spurious signal removal was demonstrated by principal coordinate and co-occurrence analysis. For example, analysis of
taxon co-occurrence in adenoid swab and middle ear fluid samples indicated that failure to remove the spurious
signal resulted in the inclusion of six out of eleven bacterial genera that accounted for 80% of similarity between
the sample types.
Conclusions: The application of the presented workflow to a set of challenging clinical samples demonstrates its
utility in removing the spurious signal from the dataset, allowing clinical insight to be derived from what would
otherwise be highly misleading output. While other approaches could potentially achieve similar improvements,
the methodology employed here represents an accessible means to exclude the signal from contamination and
other artefacts.
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The development of high-throughput, low-cost, sequen-
cing has greatly expanded the ability of researchers to
investigate complex bacterial systems associated with the
human body. In particular, 16S rRNA gene amplicon se-
quencing has been used widely, most commonly in the
characterisation of samples from ‘high biomass’ sites
such as the gastrointestinal tract. Samples from such
contexts are comparable in richness and complexity to
some of the environmental microbial systems for which
high-throughput sequencing technology was pioneered,
allowing the technology to be applied with relatively
minor modifications. However, amplicon- sequencing
approaches are also being applied increasingly to ana-
tomical [1,2] and environmental sites [3] that contain
very low levels of bacteria such as the distal airways in
the absence of an infection [1,2]. Here, a number of fac-
tors can have a major impact on the data generated.
These include a reduction in PCR amplification effi-
ciency due to high levels of human nucleic acids and
low levels of bacterial 16S rRNA gene copies that result
in increased sampling bias. Of particular concern is the
contribution of low levels of signal from non-bacterial
DNA and bacterial DNA present as reagent contamin-
ation [4], which would not substantially affect sequen-
cing data in samples containing high concentrations of
bacterial template. Such a spurious signal can substan-
tially distort community profiles from samples with low
bacterial load [4-6]. When 16S rRNA gene sequencing is
applied to such contexts without due consideration of
these factors, it can give rise to a conclusion that is po-
tentially misleading [4,7]. The impact of failing to per-
form necessary data processing steps to render data
accurate and clinically informative can be particularly
problematic in studies that rely on commercial-
sequencing providers. The absence of these steps,
which are not standard for commercial-sequencing
firms, has resulted in an increasing body of literature,
whose quality is highly variable [4]. Nevertheless, some
well-conducted studies have attempted to address these
issues, providing clinically robust conclusions [8].
Our aim was to develop a methodology that allows
non-specialist researchers to derive accurate and clinic-
ally informative data from Illumina MiSeq-based pair-
end 16S rRNA gene profiles generated from challenging
respiratory contexts. Rather than distinguishing between
a genuine signal and a spurious signal based on subject-
ive ‘balance of probability’ assessments, our approach is
based on defined parameters that can be applied object-
ively and uniformly. Further, it was our intention that,
wherever possible, this methodology would be based on
commonly available software, with a minimal require-
ment for specialist bioinformatic expertise. By applying
our methodology to a collection of nasopharyngeal (NP)swabs, adenoid biopsies, adenoid swabs and middle ear
fluid (MEF) samples from indigenous Australian chil-
dren with otitis media with effusion (OME, the presence
of middle ear fluid behind an intact tympanic membrane
without signs or symptoms of infection), we illustrate
the beneficial impact of this workflow on bacterial com-
munity data from a challenging clinical context.
Results and discussion
The total number of sequences successfully assembled
from paired-end reads across the sample set was
2,094,672. Following quality filtering, truncation and
chimera removal, a total number of 1,706,072 sequences
advanced to operational taxonomic unit (OTU) picking
and taxonomy assignment.
Reference database selection for OTU picking and
taxonomy assignment
A number of different databases of 16S rRNA gene se-
quences can be used to assign taxonomic identities to
OTUs (Figure 1, Step 2). We compared the ability of
two of the most popular databases, Greengenes (v13.8)
[9] and SILVA (v111) [10], to assign identities to OTUs
generated from a multi-template control comprised of
known species at defined relative abundance. These
two databases were found to perform quite differently
(Additional file 1: Tables S2, S3 and S4). Using identical
OTU picking and taxonomic assignment methods, the
Greengenes representative set did not assign taxonomy
to eight of the top seventeen most abundant OTUs in the
multi-template control (MTC). Importantly, Greengenes
failed to assign Moraxella or Staphylococcus (common
upper-airway colonisers) to any of the top 17 OTUs. In
contrast, the SILVA representative dataset only failed to
assign taxonomy to five of the top seventeen OTUs (and
none of the top ten) and successfully assigned taxonomy
to the most abundant Moraxella (17.6% relative abun-
dance) and Staphylococcus OTUs observed in the MTC.
Based on this analysis, SILVA was selected as the reference
database for OTU picking and taxonomic assignment.
Selection of OTU picking and taxonomic assignment
strategy
We investigated three OTU picking approaches available
in quantitative insights into microbial ecology (QIIME)
as follows: de novo OTU picking, open-reference and
closed-reference OTU picking (Figure 1, Step 2). Clas-
sical de novo OTU clustering and taxonomic assignment
resulted in 108,099 individual OTUs clustered at 97%
similarity with the majority of these OTUs ‘unclassi-
fied’ according to the representative set of sequences.
Using sequence classification tool Kraken v0.10.5,
61.27% of all reads in the dataset were found to be
non-bacterial sequences aligned to the human genome
Figure 1 Workflow of bioinformatic and biostatistical analysis.
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novo strategy was unable to eliminate these reads as a
non-bacterial signal and instead classified the reads as
unclassified. Using open-reference OTU picking, the
percentage of the unclassified reads decreased to 2.5%
with only 2,096 OTUs identified. The open-reference
OTU picking method successfully eliminated the non-
bacterial human signal associated with the de novo
strategy while retaining unclassified bacterial reads.
For example, retained unclassified bacterial reads suchas Alloiococcus were >60% similar (the pre-filter cut-
off ) and <95% similar (the taxonomic assignment cut-
off ) to the SILVA database. Closed-reference OTU
picking performed poorly as a number of high relative
abundance OTUs were unclassified and eliminated
from the final-output OTU table. In closed-reference
OTU picking, all reads <97% similar to the SILVA
database were discarded, meaning taxa such as Alloio-
coccus were unclassified and eliminated from the data-
set, despite the open-reference method returning a
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in the MEF samples. Accordingly, the open-reference
method for OTU picking was employed for all further
analyses.
Impact of pre-filtering on adenoid sample types
The impact of the pre-filtering step in open-reference
OTU picking, which eliminated the non-bacterial signal,
was demonstrated by the analysis of the differences ob-
served across the adenoid specimen sample types. A sig-
nificantly higher percentage of reads in each sample
were removed by pre-filtering from the adenoid biopsies
(93.8%, SD 0.02), which contain high levels of human
material relative to bacterial content, compared to the
adenoid swabs (78.4%, SD 0.13) (t-test, P = 0.002)
(Figure 2A). As discussed above, aligning sequences to
the human genome (GRcH38) indicated that these reads
were derived from human DNA. Where a high percent-
age of the total reads in the biopsies were human, the
resulting yield of bacterial sequences was significantly
lower, with a median of 947 (IQR 2507) reads in the ad-
enoid swabs and 94 reads (IQR 76) in adenoid biopsies
(Mann–Whitney P < 0.0001). The disparity in bacterial
reads obtained from the adenoid swabs compared to
the biopsies strongly suggest reduced 16S rRNA gene
amplification efficiency, most likely due to competitive
or inhibitory interactions arising from the high levels of
non-bacterial DNA in the adenoid biopsies. We note
there are a variety of stand-alone methods available to
eliminate this type of non-bacterial signal, such as Decon-
Seq [12], Kraken [11] and FastQ Screen (Babraham
Bioinformatics, Babraham Institute, UK). However, by
utilising parameters in QIIME, we were able to achieve
an efficient removal of the non-bacterial signal within
the QIIME pipeline.Figure 2 Proportion of sequence reads removed from adenoid swab compa
human OTUs in adenoid swab (n = 11) and adenoid biopsies (n = 11). ***P < 0
as artefact in adenoid swab and adenoid biopsies. *P < 0.032, Mann–WhitneyIdentification and removal of contaminants based on OTU
distribution relative to biomass
Following pre-filtering, the second stage of the pipeline in-
volved the removal of presumed contaminants (Figure 1,
Step 3). The relative abundance of all OTUs identified as
potential reagent contamination showed a strong inverse
correlation with amplicon concentration after 16S library
preparation (R = −0.64, P < 0.0001, Spearman’s correlation)
(Figure 3). This significant inverse relationship was also
demonstrated at the individual OTU level (Figure 4A, B,
and C). In contrast, OTUs representing genera thought
not to be reagent contaminants showed no such correl-
ation (Figure 4D, E and F). Such a relationship has been
reported previously, based on 454 sequencing data [6].
OTUs were therefore removed on an objective basis,
where a significant Spearman’s correlation (P ≤ 0.05) be-
tween amplicon concentration and OTU relative abun-
dance was observed.
The relative abundance of reagent contaminants was
significantly higher in the adenoid biopsies (median = 46%,
IQR 37%) compared to the adenoid swabs (median = 18%,
IQR 21%, P = 0.032, Mann–Whitney U test) (Figure 2B),
consistent with our observation that the biopsies had re-
duced bacterial amplification efficiency. In addition, MEF
samples also had a high relative abundance of reagent con-
taminants (median = 26%, IQR 24%). The high relative
abundance of reagent contaminants in the MEF samples
was also in the context of low biomass, with only eight out
of twenty-two MEF samples successfully amplifying above
the limit of detection in the total bacterial load qPCR (bac-
terial load in these swabs ranged from 1.7 × 104 to 9.6 ×
104 copies ml−1 of MEF). By comparison, NP swabs had a
contamination median relative abundance of only 0.2%
(IQR 1.1%). Not surprisingly, this was in the context of
the highest observed bacterial loads, with ten out of
eleven swabs amplifying successfully (bacterial load inred to adenoid biopsy. (A) Proportion of reads removed by pre-filtering
.002, Mann–Whitney test. (B) Relative abundance of sequences identified
test.
Figure 3 Relative abundance of OTUs identified as potential sequencing
artefact plotted against amplicon concentration following library
preparation. Spearman’s rho (ρ) and significance of correlation
are shown.
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ml−1 of swab and a mean of 22,431 non-contaminant
bacterial sequences (SD 9,276)). Nasal cavity and NP
swabs are the mainstay of upper-respiratory micro-
biome studies [5] and were less subject to the effect of
non-bacterial DNA and reagent contaminants that we
have observed in the other sample types (MEF and ade-
noid biopsy samples). The NP swabs therefore provided
us with a baseline to assess how other lower biomass
sample types behave using identical laboratory and bio-
informatic methods.
It is important that the removal of contaminant taxa is
performed at the OTU level. A number of genera known
to be common colonisers of the upper-respiratory tract
(Stenotrophomonas and Pseudomonas) have been identi-
fied as common reagent contaminants. Analysis of the
distribution of these taxa at a genus level, where mul-
tiple OTUs are included in one correlation plot, could
be misleading if some OTUs within that genus are spuri-
ous and others are not. Further, if researchers are con-
cerned that there may be a mixture of genuine and
contaminating reads within a single OTU clustered at
97% similarity, further analysis within that OTU could
be performed. Differentiation might, for example, be
achieved by clustering OTUs at a similarity of 100% and
plotting each of the resulting OTUs against amplicon
concentration. Ultimately, such removal of contaminants
based on the relationship between OTU distribution and
amplicon concentration may be fully automatable.
The contribution of sequence reads that were removed
at the pre-filtering step, removed after being identified
as reagent contamination, or that were representative of
presumed genuine bacterial signal are summarised foreach of the four sample types in Figure 5. In the absence
of pre-filtering and reagent contaminant removal, me-
dian relative abundance of presumed genuine bacterial
signal in the NP swabs was above 85%, suggesting that
potentially meaningful results from the NP swabs may
have been achieved using other methods. Adenoid swabs
and MEFs, however, contained low levels of bacteria and
high levels of human DNA, with a median relative abun-
dance of presumed bacterial signal lower than 15%. In
these circumstances, an overwhelming spurious signal
made it nearly impossible to derive accurate 16S data with-
out pre-filtering and removing potential contamination.
Impact of potential reagent contamination on measures
of microbiota similarity
To assess the impact of reagent contaminants in the
dataset, we performed principal coordinate analysis
(PCoA) based on sequence data before and after their
removal (Figure 6A and B). Following the removal of
contaminant OTUs, the NP and adenoid swabs showed
a more proximal distribution. In contrast, the separation
between MEFs and the other two sample sites increased.
Analysis of similarity (ANOSIM) tests were used to de-
termine whether differences between the distributions of
the microbiota profiles from the three samples sites were
significant. Both filtered and non-filtered datasets showed
highly significant differences between the MEF and upper-
airway samples (P < 0.001). The R-statistic for the filtered
data set was 0.66 compared to 0.48 for the non-filtered
data indicating that MEF samples were more dissimilar
from the upper-airway samples following the removal of
contaminant OTUs.
The impact of OTUs filtered from the dataset upon in-
terpretation was further illustrated by an analysis of co-
occurrence. The occurrence and co-occurrence of taxa
present in each of the three sample types are shown
based on non-filtered and filtered data (Figure 7A and B,
respectively). To illustrate disparity, we highlight the co-
occurrence of taxa in the adenoid swab and MEF, where
12 taxa are present at both sites when filtering is not
performed, but this is reduced to three common coloni-
sers of the upper airways with filtering (Moraxella, Hae-
mophilus and Streptococcus). Taxa removed included
Ralstonia, Variovorx, Escherichia, Brevundimonas, Chry-
seobacterium, Pedobacter and Pseudomonas. This ob-
servation was confirmed by similarity of percentage
(SIMPER) analysis, where six out of the eleven OTUs
contributing to 80% of the similarity between the MEF
and adenoid swabs were identified as presumed reagent
contaminants. Failure to identify these contaminants in
the context of comparing the microbiome of the aden-
oids and MEFs in children with otitis media has the po-
tential to produce highly misleading clinical findings.
As the nasopharynx and adenoids are considered to be
Figure 4 Relative abundance of presumed contamination and genuine signal plotted against amplicon concentration. Relative abundance of
OTUs of sequencing artefacts (A-C) and non-artefacts (D-F) plotted against amplicon concentration following library preparation. Spearman’s rho
(ρ) and significance of correlation are shown.
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any organisms identified in adenoid and MEF samples
would ordinarily be considered of potential clinical im-
portance in the pathogenesis of this condition. How-
ever, as shown in our analysis, six out of eleven of the
OTUs contributing to 80% of the similarity between
the adenoids and MEFs were reagent contaminants.
Conclusions
Currently, there is considerable interest in understanding
the relationships between complex airway microbiota, host
physiology and the development and progression of dis-
ease. In many cases, the low cost of high-throughput
amplicon sequencing provide an opportunity to re-
searchers and clinicians to perform such studies. However,
while these technologies are commonly accessible, their
application alone is not sufficient to provide informative
data, particularly where airway samples contain low levels
of microbes and/or high levels of human DNA. Carefulbioinformatic processing is required to minimise the
substantial impact of the spurious signal and to avoid
basing clinical interpretation on potentially misleading
output [14].
We describe a workflow for the removal of the spuri-
ous signal that can be applied using commonly available
tools and without the need for highly specialised bio-
informatics expertise. This approach could be easily
applied to non-human studies and is not necessarily spe-
cific to 16S rRNA studies, as metagenomic approaches
encounter similar issues [15]. To assess the efficacy of
this approach, we applied it to the processing of micro-
biota data from human respiratory samples using largely
standard protocols for DNA extraction, library prepar-
ation and sequencing. Specifically, we analysed sample
types that contained different levels of bacterial and
non-bacterial DNA. While our results suggest that for
some sample types such as NP swabs, reasonably high
quality data can be obtained without the need for stringent
Figure 5 Proportion of sequence reads removed by pre-filtration or when identified as contaminants. The proportion of the total number of
sequence reads obtained that were removed at the pre-filtering step or after being identified as potential contamination are shown for each of
the four sample types. Also shown, the proportion of total sequence reads that were representative of the bacterial signal. Proportions do not
sum up to 100% in each sample type as the reads removed as contaminants are shown as a proportion of the filtered reads.
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bacterial biomass samples (MEF, adenoid swabs and ade-
noid biopsies) means that comparisons of microbial com-
munities across all sample types is not possible in its
absence. Further, parallel analysis of bacterial community
distributions, with and without the removal of this signal,
clearly indicated that failure to apply this methodology
would have resulted in data that were misleading, pointingFigure 6 Principal coordinate plots based on a BC similarity matrix of bact
ear fluid and nasopharyngeal swabs are shown before (A) and after (B) rem
adenoid swabs, 13 middle ear fluid and 11 N swabs, with panel B based onas it did to greater communication between anatomical
sites than was indeed the case.
It is important to note that the level of the spurious
signal within the sequencing data will be influenced by a
wide range of factors and may differ substantially with
sampling strategies, anatomical sites and even between
replicate samples. Further, the fact that reagent contam-
ination can be almost impossible to exclude entirely anderial community sequence data. Distribution of adenoid swabs, middle
oval of signal derived from contaminants. Panel A is based on 11
10 adenoid swabs, 11 middle ear fluid and 11 nasopharyngeal swabs.
Figure 7 Co-occurrence plots for genera detected in adenoid swabs, middle ear fluid, and nasopharyngeal swabs. Plots are shown for data before
(A) and after (B) removal of the signal derived from contaminants. Genera detected in both adenoid and MEF are highlighted. Note that Achromobacter
was not removed based upon spurious distribution. However, following the removal of all contaminant OTUs and rarefaction to 400 reads, the sample
with Achromobacter at >1.5% relative abundance was removed due to low sequencing depth. The removal based on spurious distribution of
a Rhizobium OTU, detected in both NP and MEF, is also shown.
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amplify sequences from as great a proportion of bacter-
ial species as possible, mean that the likelihood of pre-
venting non-specific amplification is very low. As such,
the development of an error-free method for generating
16S rRNA sequence data from clinical samples would
seem highly unlikely. Methods that are able to remove
spurious signal post-sequencing are therefore important
protocol adjuncts. While we do not suggest that the
methodology described here is definitive or that other
approaches could not achieve similar results, we feel that
our workflow provides a means for bench-top biologists
with minimal bioinformatics experience to process data
from challenging clinical contexts.Methods
Samples were collected as part of the National Health
and Medical Research Council-funded (Grant 1007641)
randomised controlled trial of surgical interventions for
OME (Australia and New Zealand Clinical Trials Regis-
tration 12611001073998). Samples were collected at
baseline from children undergoing surgery at the Alice
Springs Hospital during May and June 2014. Ethical ap-
proval was obtained in the Northern Territory through
the Central Australian Human Research Ethics Commit-
tee (HOMER 12 to 16) and Menzies School of Health
Research Ethics Committee (2011 to 1686).Surgical procedures and sample collection
The clinical samples included 11 nasopharyngeal (NP)
swabs, 22 middle ear fluid samples (MEFs) in saline (left
and right ear of each child) and 11 adenoid biopsies.
Swabs of the exterior of the adenoid biopsies were taken
prior to DNA extraction. Full details of the surgicalprocedures and sample collection protocols are provided
in Additional file 1.
DNA extraction and estimation of total bacterial load
The total DNA was extracted from all clinical samples
and two DNA extraction reagent negative controls. Full
details of the DNA extraction protocols are provided in
Additional file 1. Total bacterial load was determined as
described previously [16] and was used to assess tem-
plate concentrations for 16S rRNA amplicon sequen-
cing. Full details of the qPCR protocol are provided in
Additional file 1. A multi-template control (MTC) con-
sisting of thirteen species in known relative abundance
was used in the assessment of OTU picking and taxo-
nomic assignment protocols. Full details of this MTC
are given in Additional file 1: Table S1.
16S rRNA gene amplicon library preparation and
sequencing
Amplicons were generated using fusion degenerate primers
27 F (5’-TCGTCGGCAGCGTCAGATGTGTATAAGAGA
CAGAGRGTTTGATCMTGGCTCAG-3’) and 519R (5’-
GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGT
NTTACNGCGGCKGCTG-3’) with ligated overhang Illu-
mina adapter consensus sequences in italic text. Full details
of the library preparation and sequencing protocol are pro-
vided in Additional file 1. In brief, the initial PCR reactions
were performed on a Veriti 96-well Thermal Cycler (Life
Technologies, Australia). The PCR reactions were per-
formed in the following programme: initiation enzyme ac-
tivation at 95°C for 3 min, followed by 25 cycles consisting
of denaturation at 95°C for 30 sec, annealing at 55°C for
30 sec and extension at 72°C for 30 sec. After 25 cycles,
the reaction was completed with a final extension of 7 min
at 72°C.
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Diego. CA, USA) with dual 8-base indices were used to
allow for multiplexing. Two unique indices located on
either end of the amplicon were chosen based on the
Nextera dual-indexing strategy. To incorporate the indi-
ces to the 16S amplicons, PCR reactions were performed
on a Veriti 96-well Thermal Cycler (Life Technologies,
Australia). Cycling conditions consisted of one cycle of
95°C for 3 min, followed by eight cycles of 95°C for
30 sec, 55°C for 30 sec and 72°C for 30 sec, followed by
a final extension cycle of 72°C for 5 min.
Prior to library pooling, the barcoded libraries were
quantified using the Qubit dsDNA HS Assay Kit (Life
Technologies, Carlsbad, CA, USA). Results from this
quantification step (amplicon concentration) were used
in downstream processing to eliminate contamination
(Figure 1, Step 3). The libraries were sequenced by 2 ×
300 bp paired-end sequencing on the MiSeq platform
using MiSeq v3 Reagent Kit (Illumina) at the Flinders
Genomics Facility, Adelaide, Australia. All sequence data
generated have been submitted to the Sequence Read
Archive [17].
Bioinformatic processing
An overview of the bioinformatic workflow used is
shown in Figure 1. FastQC v.11.2 (Babraham Bioinfor-
matics, Babraham Institute, UK) was used to analyse the
average quality scores of each sample before and after
pairing reads. The Paired-End reAd mergeR (PEAR)
v.0.9.5 [18] was used to pair the forward and reverse
reads of sequences in each sample and discard all se-
quences less than 450 bp and/or with a Phred score <33.
Kraken v0.10.5 [11] was used to classify sequences
against pre-built databases of viral and bacterial sequences
and the human genome (GRcH38). The pre-built data-
bases (MiniKraken) were downloaded from the Kraken
website (https://ccb.jhu.edu/software/kraken/ accessed
03032015), and query sequences were classified using
Kraken’s default parameters.
Samples were then demultiplexed using QIIME v.1.8.0,
with individual sequences assigned to their original sam-
ples. The demultiplex step contained further quality
filtering steps as follows: truncation following three con-
secutive low quality base calls, removal of reads with <75%
high quality base calls and removal of sequences with an
unclear base call (N). Chimeras were filtered with a
reference-based approach using UCHIME v.4.2 [19]
and a representative set of chimera-checked sequences
(Greengenes v.13.8; [9]).
For OTU picking, we used QIIME [20] as opposed to
other popular 16S data analysis pipelines such as mothur
[21]. We found the clustering mechanism employed by
mothur version 1.34.3 unsuitable for processing paired-
end read sequence data. In brief, the mothur MiSeqstandard operating procedure relies on an OTU-clustering
mechanism (nearest, furthest or average neighbour clus-
tering) that generates a distance matrix, optimised when
large data sets are condensed into a small number of iden-
tical sequences using the unique.seqs command. MiSeq
sequencing generates paired-end reads with the potential
for errors in the paired region of the sequences as previ-
ously described [18]. Consequently, when applied to large
Illumina data sets, the unique.seqs command may be un-
able to condense data to an appropriate size for the dis-
tance matrix, resulting in excessive wall time during
clustering. QIIME provides various OTU-clustering ap-
proaches (including those employed by mothur), some of
which do not require generation of a large distance matrix
(for example, UCLUST [22]).
Traditional de novo OTU picking, closed-reference and
open-reference OTU picking were performed in QIIME.
In de novo OTU picking, all reads were clustered based
upon 97% similarity to each other, irrespective of similarity
to known 16S rRNA sequences [23]. Taxonomy of de novo
OTUs was assigned at 95% similarity to a representative
set (rep-set) of 16S rRNA sequences in the SILVA data-
base (release 111, July 2013) [10]). In closed-reference
OTU picking, all reads were clustered based upon 97%
similarity to a reference sequence in the rep-set, with all
unassigned sequences discarded.
In open-reference OTU picking [24], all sequences were
initially pre-filtered to discard sequences not meeting a
threshold of 60% similarity to the rep-set. A closed-
reference OTU-picking step was then performed, where
all reads were clustered based upon 97% similarity to the
rep-set. Reads failing to meet the 97% similarity threshold,
were then clustered de novo (described above). OTU maps
created for the closed-reference and de novo steps were
then merged to create a combined OTU map. A represen-
tative set of sequences was created from the combined
OTU map and taxonomy was assigned as described above.
In the de novo, closed- and open-reference approaches,
UCLUST [22] v.1.2.22 was used to cluster OTUs at 97%
similarity. Analysis of a multi-template control was used
to assess suitability of 16S rRNA reference databases for
the taxonomic assignment. Taxonomic assignment for all
three OTU picking methods was performed at 95% simi-
larity to the rep-set using UCLUST.
Biostatistical analysis
All samples were filtered to retain OTUs with a relative
abundance of ≥1% in at least one sample. This allowed for
manual inspection of individual OTUs for potential re-
agent contaminants. OTUs previously reported as com-
mon artefacts in sequence data from low biomass clinical
samples were identified from the filtered OTU table
[4]. The relative abundance of these OTUs was com-
pared to the amplicon concentration measured during
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tered from the data set if the distribution was inversely
correlated with amplicon concentration, suggestive of a
spurious signal generated in the absence of a preferen-
tially amplified template [6]. In addition, OTUs identi-
fied in the DNA extraction negative controls were
filtered from the sequence data. A complete list of
OTUs removed in these steps is provided in Table 1,
with sequences corresponding to OTU identities in-
cluded in Additional file 2.Table 1 OTUs removed from sequencing data prior to
biostatical analysis
Genus OTU identity
Achromobacter JF925009
Acidovorax JN869209, HQ681993
Bergeyella New. CleanUp. ReferenceOTU46637
Brevundimonasa EF600592
Candidatus Planktoluna FN668204
Cellulosimicrobium New. CleanUp. ReferenceOTU1526
Chryseobacteriuma New. ReferenceOTU87, New.
CleanUp. ReferenceOTU40460, New.
CleanUp. ReferenceOTU30994,
AY46848
Clavibacter New. ReferenceOTU27
Devosia AY162048
Flavobacterium New. ReferenceOTU91, New. CleanUp.
ReferenceOTU22231
Gelidibacter New. CleanUp. ReferenceOTU10780
Janthinobacterium EU801443
Mesorhizobium DQ228360
Ochrobactrum DQ860022
Pedobacter New. CleanUp. ReferenceOTU91
Pelomonasa JF733429, FJ269077
Phyllobacteriuma GQ255500
Pseudomonasa JN187532, JF970596, GU272272,
FJ347714,
EF515711
Ralstoniaa GU940710
Rhizobium GQ472936
Rhodanobacter New. CleanUp. ReferenceOTU3920
Sphingomonas EF098188
Stenotrophomonas FJ184356, AY373393
Terrimonas New. CleanUp. ReferenceOTU20538
Turicibacter AY953239
Undibacterium GU940681
Variovoraxa GU731299, GU272259
aIndicates contaminant OTUs detected in the DNA extraction negative
controls. Sequences corresponding to OTU identities are included in
Additional file 2 (filtered_contaminants.fna). Where accession numbers are
given for OTU identities, the representative sequence from our dataset is 97%
similar to the actual sequencing pertaining to that accession number.OTUs that were not classified below family-level by
taxonomic assignment based on the rep-set were further
classified to obtain a genus- and species-level identifica-
tion. This was achieved by aligning representative se-
quences of each selected OTU to the 16S ribosomal
RNA sequence database and National Center for Bio-
technology Information (NCBI) database using the Basic
Local Alignment Search Tool (BLAST) [25]. Presumptive
identification was made if an aligned sequence returned
an identification coverage score of ≥97%. Where repre-
sentative sequences aligned to multiple species with an
identical coverage score ≥97%, a higher-level taxonomic
identifier was assigned.
Rarefaction curves were generated in QIIME for all
contaminant-filtered and non-filtered samples. Appro-
priate subsample depth was established by visual inspec-
tion of rarefaction curves to ensure adequate sample
depth while retaining low read samples. It was confirmed
that reducing the sequence number in this way did not re-
sult in a significant reduction in profile diversity, as deter-
mined using the Simpson’s Index of Diversity (1-D)
(Additional file 1: Figure S1). Accordingly, all samples
were subsampled to 400 reads. Subsampling eliminated
34% of all samples (22 out of 64 samples) including 9 out
of 11 adenoid biopsy samples from the contaminant-
filtered data (due to low sequencing depth). Consequently,
adenoid biopsy data were not used in the calculation of di-
versity estimates for the comparison of filtered and non-
filtered sequences.
Diversity estimates were performed before and after
OTU filtering to compare its effect across sample types.
Bray-Curtis (BC) similarity matrices were created using
QIIME for principle coordinates analysis (PCoA) and
PRIMER v.6 (PRIMER-E Ltd, Plymouth, UK) for SIMi-
larity of PERcentages (SIMPER) and Analysis of similar-
ity (ANOSIM) analyses. SIMPER was used to determine
the contribution made by specific OTUs to the observed
similarity between sample types before and after con-
taminant filtering. ANOSIM was also performed in PRI-
MER to test whether there was a statistically significant
difference between the MEF and the combined upper-
airway samples (NP and adenoid swabs) before and after
contaminant filtering.
Mann–Whitney U tests or t-tests were used to test
variation in these measures between the adenoid biopsies
and swabs, depending on data distribution. The relative
abundance of OTUs was plotted relative to amplicon con-
centration using GraphPad Prism v.6.04 (GraphPad
Software Inc. California, USA) with the significance
tested by Spearman’s correlation. Cytoscape v2.8.2 [26]
was used to create a co-occurrence model. A work-
sheet with the presence or absence of each OTU ob-
served at >1.5% relative abundance was generated,
showing which sample types contained identical OTUs.
Jervis-Bardy et al. Microbiome  (2015) 3:19 Page 11 of 11This spreadsheet was then uploaded to Cytoscape to
generate Figure 7.
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